Status:
UNKNOWN
Opiate Use and Biliary Dilation
Lead Sponsor:
Stanford University
Conditions:
Evaluation of Association Between Opiate Use and Biliary Dilation
Eligibility:
All Genders
Brief Summary
We hope to better define the association between opiate use and biliary dilation, which was evident in our previous retrospective study. This prospective study including all endoscopic ultrasound proc...
Detailed Description
We hope to better define the association between opiate use and biliary dilation, which was evident in our previous retrospective study. This prospective study including all endoscopic ultrasound proc...
Eligibility Criteria
Inclusion
- Referral/consultation for consideration for EUS ± ERCP
- Age 18 and older
- Evidence of biliary dilation on abdominal imaging without obstructive pattern on liver function tests or imaging.
- Willing and able to comply with the study procedures and provide written informed consent to participate in the study.
Exclusion
- Age \<18
- Potentially vulnerable subjects including, homeless people, pregnant females, employees and students.
- Participation in another investigational study that may directly or indirectly affect the results of this study within 30 days prior to the initial visit
- Other biliary process which accounts for patient's abnormal liver function studies/imaging (i.e. mass, stone, cirrhosis).
Key Trial Info
Start Date :
January 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03870347
Start Date
January 3 2018
End Date
January 1 2022
Last Update
March 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University Medical Center
Stanford, California, United States, 94304